South Africa Receives First Lenacapavir HIV Prevention Doses Ahead of Irish Quality Checks

South Africa has received its first shipment of nearly 38,000 doses of Lenacapavir, a new HIV prevention medicine. The doses are now set for quality checks in Ireland before wider distribution. This development is important as it could enhance HIV prevention efforts in South Africa, a country with a high HIV prevalence. The introduction of Lenacapavir may improve treatment options and reduce new infections.